Surennaidoo P Naiken Christian Toso Laura Rubbia-Brandt Theodoros Thomopoulos Arnaud Roth Gilles Mentha Philippe Morel Pascal Gervaz
10.1186/1471-2482-14-4
BMC Surg
2014 Jan 17;14:4.
CC BY
https://pubmed.ncbi.nlm.nih.gov/24438090/
Adenocarcinoma / drug therapy Adenocarcinoma / secondary Antineoplastic Combined Chemotherapy Protocols / therapeutic use Liver Neoplasms / drug therapy Liver Neoplasms / secondary Rectal Neoplasms / drug therapy Rectal Neoplasms / pathology
Adenocarcinoma / drug therapy Adenocarcinoma / secondary Antineoplastic Combined Chemotherapy Protocols / therapeutic use Liver Neoplasms / drug therapy Liver Neoplasms / secondary Rectal Neoplasms / drug therapy Rectal Neoplasms / pathology Case Reports Research Support, Non-U.S. Gov't Adenocarcinoma / surgery Aged Antibodies, Monoclonal, Humanized / administration & dosage Antineoplastic Agents / administration & dosage Bevacizumab Camptothecin / administration & dosage Camptothecin / analogs & derivatives Chemotherapy, Adjuvant Fluorouracil / administration & dosage Hepatectomy Humans Irinotecan Leucovorin / administration & dosage Liver Neoplasms / surgery Male Neoadjuvant Therapy Neoplasm Staging Organoplatinum Compounds / administration & dosage Oxaliplatin Rectal Neoplasms / surgery Rectum / surgery Antibodies, Monoclonal, Humanized Antineoplastic Agents Organoplatinum Compounds Oxaliplatin Bevacizumab Irinotecan Leucovorin Fluorouracil Camptothecin
PMC3900671
24438090
Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer
2014